KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to -$241000.0.

  • Aquestive Therapeutics' Change in Inventory fell 53818.18% to -$241000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $863000.0, marking a year-over-year increase of 158793.1%. This contributed to the annual value of -$725000.0 for FY2024, which is 17330.64% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Change in Inventory stood at -$241000.0 for Q3 2025, which was down 53818.18% from $927000.0 recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Change in Inventory ranged from a high of $1.7 million in Q3 2022 and a low of -$1.0 million during Q2 2023
  • In the last 5 years, Aquestive Therapeutics' Change in Inventory had a median value of $338000.0 in 2021 and averaged $285473.7.
  • Its Change in Inventory has fluctuated over the past 5 years, first soared by 705416.67% in 2022, then tumbled by 53818.18% in 2025.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Change in Inventory stood at $1.2 million in 2021, then plummeted by 180.34% to -$944000.0 in 2022, then surged by 67.16% to -$310000.0 in 2023, then tumbled by 215.16% to -$977000.0 in 2024, then skyrocketed by 75.33% to -$241000.0 in 2025.
  • Its last three reported values are -$241000.0 in Q3 2025, $927000.0 for Q2 2025, and $1.2 million during Q1 2025.